0000950170-24-047557.txt : 20240424 0000950170-24-047557.hdr.sgml : 20240424 20240424160021 ACCESSION NUMBER: 0000950170-24-047557 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20240418 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240424 DATE AS OF CHANGE: 20240424 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KINETA, INC./DE CENTRAL INDEX KEY: 0001445283 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37695 FILM NUMBER: 24870473 BUSINESS ADDRESS: STREET 1: 7683 SE 27TH STREET STREET 2: SUITE 481 CITY: MERCER ISLAND STATE: WA ZIP: 98040 BUSINESS PHONE: (206) 378-0400 MAIL ADDRESS: STREET 1: 7683 SE 27TH STREET STREET 2: SUITE 481 CITY: MERCER ISLAND STATE: WA ZIP: 98040 FORMER COMPANY: FORMER CONFORMED NAME: YUMANITY THERAPEUTICS, INC. DATE OF NAME CHANGE: 20201223 FORMER COMPANY: FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS, INC. DATE OF NAME CHANGE: 20140813 FORMER COMPANY: FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS INC DATE OF NAME CHANGE: 20080916 8-K 1 ka-20240418.htm 8-K 8-K
false0001445283KINETA, INC./DENASDAQ00014452832024-04-182024-04-18

UNITED STATES

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 18, 2024

 

 

 

KINETA, INC.

 

(Exact name of registrant as specified in its charter)

 

 

 

Delaware

001-37695

20-8436652

(State or other jurisdiction

(Commission

(IRS Employer

of incorporation)

File Number)

Identification No.)

7683 SE 27th Street, Suite 481

 

 

Mercer Island, WA

 

98040

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (206) 378-0400

 

Not Applicable

 

(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading

Name of each exchange

 

 

Symbol(s)

on which registered

 

Common Stock, par value $0.001 per share

 

KA

 

The Nasdaq Capital Market

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 


 

Item 1.01 Entry into a Material Definitive Agreement.

 

On April 22, 2024, Kineta, Inc. (the “Company”) entered into a settlement agreement and mutual release (the “Agreement”) by and between the Company and RLB Holdings Connecticut, LLC (“RLB”) to continue RLB’s investment in the Company and to resolve any and all potential claims or causes of action in connection with RLB’s failure to purchase $2,500,000 shares of the Company’s common stock, par value $0.001 per share (“Common Stock”), pursuant to a financing agreement, dated as of June 5, 2022, as amended on October 24, 2022, December 5, 2022, March 29, 2023, May 1, 2023, July 21, 2023 and October 13, 2023.

Pursuant to the Agreement, within five (5) days of the Agreement, RLB shall purchase $500,000 of shares of Common Stock, to be adjusted as necessary to avoid the issuance of any fractional shares (the “Share Purchase Price”), and in exchange, within ten (10) days of receiving the Share Purchase Price, Kineta shall issue to RLB such number of shares of Common Stock equal to the Share Purchase Price divided by the sum of (i) the Nasdaq Official Closing Price of Common Stock for the five trading days prior to the date of the Agreement (the “NOCP”) and (ii) 20% of the NOCP.

The foregoing summary of the terms of the Agreement is subject to, and qualified in its entirety by reference to, the full text of the Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

 

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

Nasdaq Bid Price Deficiency Letter

On April 18, 2024, the Company received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Rule”) because the Company has not maintained a minimum closing bid price of the Company’s common stock of at least $1.00 per share for the last 30 consecutive business days. The Notice has no immediate effect on the listing or trading of the Company’s securities.

The Company has 180 calendar days from the date of the Notice, or until October 15, 2024, to regain compliance. If the Company is not deemed in compliance before the expiration of the 180 day compliance period, it will be afforded an additional 180 day compliance period, or until April 13, 2025, provided that on the 180th day of the first compliance period it meets the applicable market value of publicly held shares requirement for continued listing and all other applicable standards for initial listing on The Nasdaq Capital Market (except the bid price requirement) based on the Company’s most recent public filings and market information and provides written notice to Nasdaq of its intention to cure this deficiency during the second compliance period.

Compliance can be achieved during any compliance period by meeting the applicable standard for a minimum of 10 consecutive business days during the applicable compliance period, unless Nasdaq exercises its discretion to extend this 10 day period as discussed in Rule 5810(c)(3)(H).

If the Company does not regain compliance with the bid price requirement within the compliance period, the Company’s common stock will be subject to delisting. In the event the Company receives notice that the Company’s common stock is being delisted, Nasdaq’s rules permit the Company to appeal the delisting determination by the Nasdaq staff to a hearings panel.

The Company intends to monitor the bid price of the Company’s listed securities and may, if appropriate, consider available options to regain compliance with the bid price requirement.

There can be no assurance that the Company will be able to regain compliance with the bid price requirement.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit

 

No. Document

 

10.1 Settlement Agreement and Mutual Release, dated as of April 22, 2024, by and between Kineta, Inc. and RLB Holdings, Connecticut, LLC

 

104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

 


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: April 24, 2024

 

Kineta, Inc.

 

By:

/s/ Craig Philips

Name:

Craig Philips

Title:

President

 

 


EX-10.1 2 ka-ex10_1.htm EX-10.1 EX-10.1

Exhibit 10.1

SEttlement Agreement and MUTUAL Release

This Settlement Agreement and Mutual Release (this “Agreement”) is entered into as of April 22, 2024 (the “Effective Date”) by and between Kineta, Inc. (“Kineta”) and RLB Holdings Connecticut, LLC (“RLB”). Kineta and RLB are referred to collectively herein as the “Parties.” Capitalized terms used but not otherwise defined herein shall have the meaning ascribed to them in the Securities Purchase Agreement (defined below).

RECITALS

WHEREAS, Kineta (formerly known as Yumanity Therapeutics, Inc.) previously entered into a financing agreement, dated as of June 5, 2022, as amended on October 24, 2022, December 5, 2022, March 29, 2023, May 1, 2023, July 21, 2023 and October 13, 2023 (such financing agreement, as amended, the “Securities Purchase Agreement”) with certain investors to sell shares of its common stock, par value $0.001 per share (“Kineta Common Stock”), in a private placement (the “Private Placement”);

WHEREAS, pursuant to the Securities Purchase Agreement, RLB agreed to purchase Kineta Common Stock in two separate closings for an aggregate purchase price of $6,840,001.60;

WHEREAS, the first closing of the Private Placement occurred on December 16, 2022 and RLB purchased 375,757 shares of Kineta Common Stock for a purchase price of $4,340,001.60;

WHEREAS, the second closing of the Private Placement, which was scheduled to occur on April 15, 2024, was not consummated due to RLB’s and the other investors’ failure to fulfill their contractual obligations to fund their respective amounts set forth in the column titled “Second Tranche Shares Aggregate Purchase Price” in Exhibit B to the Securities Purchase Agreement; and

WHEREAS, due to RLB’s failure to purchase $2,500,000 of shares of Kineta Common Stock pursuant to the Securities Purchase Agreement, the Parties are entering into this Agreement to continue RLB’s investment in the Company and to resolve any and all potential claims or causes of action, legal or equitable, in contract or tort, direct or indirect, presently asserted or not, by, between, or among the Parties that are, or could be asserted by the Parties.

THEREFORE, in consideration of the mutual promises and agreements provided herein, and for other good and valuable consideration, the sufficiency of which is hereby expressly acknowledged, the Parties agree as follows:

AGREEMENT

1.
Recitals. The above Recitals are true and correct and are hereby incorporated as part of this Agreement.
2.
Purpose. The parties desire to reach a full and final settlement and resolution of all potential claims, controversies and disputes that Kineta may have against RLB, including but not limited to all claims related in any way to RLB’s failure to purchase $2,500,000 of shares of Kineta Common Stock in connection with the second closing of the Private Placement.

1

 


 

3.
Sale of Shares to RLB; Payment. Within five (5) days of the Effective Date, RLB shall purchase $500,000 of shares of Kineta Common Stock, to be adjusted as necessary to avoid the issuance of any fractional shares (the “Share Purchase Price”), and in exchange, Kineta shall issue to RLB such number of shares (the “Shares”) equal to the Share Purchase Price divided by the sum of (i) the Nasdaq Official Closing Price of Kineta Common Stock for the five Trading Days prior to the Effective Date (the “NOCP”) and (ii) 20% of the NOCP. RLB shall pay to Kineta the Share Purchase Price in United States dollars and in immediately available funds, by wire transfer to an account designated in advance by Kineta. Within ten (10) days of receiving the Share Purchase Price, Kineta shall irrevocably instruct Equiniti Trust Company, LLC (formerly American Stock Transfer & Trust Company, LLC) to deliver to RLB the Shares in book-entry form, free and clear of all restrictive and other legends, other than the restrictive legend set forth on Exhibit A attached hereto, in RLB’s name.
4.
Release. For and in consideration of the provisions of this Agreement, Kineta hereby fully discharges and forever releases RLB and all of its representatives, heirs, successors, assigns, agents, attorneys, insurers, affiliates, trustees, and beneficiaries from any claim, cause of action, or judgment, legal or equitable, in contract or tort, direct or indirect, presently asserted or not, known or unknown, from the beginning of time to the date of this Agreement. Kineta understands and acknowledges that this release extinguishes all claims of any type that it could have against RLB including, but not limited to, those asserted, connected with, or relating to the Private Placement.
5.
No Admission of Liability. The Parties hereto understand and agree that this Agreement is a compromise of disputed claims and defenses. No action by any Party is to be construed as an admission of liability by that Party or an admission against the interest of any Party.
6.
Interpretation. The Parties have participated jointly in the negotiation and drafting of this Agreement. In the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the Parties and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of any provisions of this Agreement. By way of clarification, all references to “including” in this Agreement shall be deemed to mean “including, without limitation.”
7.
Governing Law; Dispute Resolution. This Agreement shall be governed by the laws of the State of Delaware, excluding any choice of law rules that may direct the application of the laws of another jurisdiction.
8.
Notices. Any notice required under this Agreement shall be deemed delivered upon receipt if sent by messenger or certified delivery service to the following addresses, or such other address as may be subsequently designated in writing:

TO KINETA: Kineta, Inc.

Craig W. Philips
7683 SE 27
th Street, Suite 481

Mercer Island, WA 98040

cphilips@kineta.us

 

 


 

TO RLB: RLB Holdings Connecticut, LLC

Raymond Bartoszek

343 Greenwich Ave.

Greenwich, CT 06830

ray@rlb-holdings.com

9.
Entire Agreement. This Agreement sets forth the entire agreement between the Parties and, except as set forth in this Agreement, supersedes and renders null and void all prior oral and written agreements between the Parties. This Agreement cannot be amended or modified, except in writing signed by the Parties.
10.
Severability; Further Actions. If any portion of this Agreement is found to be unenforceable, all other portions that can be separated from it, or appropriately limited in scope, shall remain fully valid and enforceable. The Parties agree to execute any further or additional documents as are reasonably necessary to effectuate the purposes of this Agreement.
11.
Successors and Assigns. This Agreement is binding upon, and inures to the benefit of, the Parties and their respective successors and assigns.
12.
Signatures. This Agreement, or any amendment hereto, may be signed in any number of counterparts, including counterparts signed and delivered by fax transmission or by e-mail delivery of a “.pdf” format data file, each of which shall be and deemed an original, but all of which taken together shall constitute one agreement (or amendment as the case may be).

 


 

 

IN WITNESS WHEREOF, the Parties have executed this Agreement effective the date all signatures below have been exchanged.

 

Kineta, Inc.

 

 

/s/ Craig W. Philips Date: 4/22/2024

Name: Craig W. Philips

Title: President and Secretary

 

RLB Holdings Connecticut, LLC

 

 

/s/ Raymond Bartoszek Date: 4/22/2024

Name: Raymond Bartoszek

Title: Manager

 

[Signature Page to Settlement Agreement]

 


 

Exhibit A

Stock Legend

THESE SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY.

 

 


EX-101.SCH 3 ka-20240418.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink Pre Commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, State or Province Entity Address, State or Province Trading Symbol Trading Symbol Soliciting Material Soliciting Material Entity Address, City or Town Entity Address, City or Town Written Communications Written Communications Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity Registrant Name Entity Registrant Name Document Period End Date Document Period End Date Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Incorporation State Country Code Entity Incorporation, State or Country Code Local Phone Number Local Phone Number City Area Code City Area Code Pre Commencement Tender Offer Pre-commencement Tender Offer Cover [Abstract] Cover [Abstract] Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Amendment Flag Amendment Flag Entity File Number Securities Act File Number Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, Address Line One Entity Address, Address Line One Security 12b Title Title of 12(b) Security Document Type Document Type XML 5 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Document and Entity Information
Apr. 18, 2024
Cover [Abstract]  
Entity Registrant Name KINETA, INC./DE
Amendment Flag false
Entity Central Index Key 0001445283
Document Type 8-K
Document Period End Date Apr. 18, 2024
Entity Incorporation State Country Code DE
Entity File Number 001-37695
Entity Tax Identification Number 20-8436652
Entity Address, Address Line One 7683 SE 27th Street
Entity Address, Address Line Two Suite 481
Entity Address, City or Town Mercer Island
Entity Address, State or Province WA
Entity Address, Postal Zip Code 98040
City Area Code (206)
Local Phone Number 378-0400
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, par value $0.001 per share
Trading Symbol KA
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
EXCEL 6 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 7 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 8 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 1 23 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.kinetabio.com/20240418/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName, dei:SecurityExchangeName - ka-20240418.htm 8 ka-20240418.htm ka-20240418.xsd http://xbrl.sec.gov/dei/2023 false false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ka-20240418.htm": { "nsprefix": "ka", "nsuri": "http://www.kinetabio.com/20240418", "dts": { "inline": { "local": [ "ka-20240418.htm" ] }, "schema": { "local": [ "ka-20240418.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 4, "http://xbrl.sec.gov/dei/2023": 4 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 24, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://www.kinetabio.com/20240418/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_d21d5ac8-63a4-48e7-a31f-1730cdf21698", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "ka-20240418.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_d21d5ac8-63a4-48e7-a31f-1730cdf21698", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "ka-20240418.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.kinetabio.com/20240418/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.kinetabio.com/20240418/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.kinetabio.com/20240418/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.kinetabio.com/20240418/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.kinetabio.com/20240418/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.kinetabio.com/20240418/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.kinetabio.com/20240418/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.kinetabio.com/20240418/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.kinetabio.com/20240418/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.kinetabio.com/20240418/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.kinetabio.com/20240418/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.kinetabio.com/20240418/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Securities Act File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.kinetabio.com/20240418/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation State Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.kinetabio.com/20240418/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.kinetabio.com/20240418/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.kinetabio.com/20240418/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.kinetabio.com/20240418/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Pre Commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.kinetabio.com/20240418/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Pre Commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.kinetabio.com/20240418/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Security 12b Title", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.kinetabio.com/20240418/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.kinetabio.com/20240418/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.kinetabio.com/20240418/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.kinetabio.com/20240418/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 14 0000950170-24-047557-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-047557-xbrl.zip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end XML 16 ka-20240418_htm.xml IDEA: XBRL DOCUMENT 0001445283 2024-04-18 2024-04-18 false 0001445283 KINETA, INC./DE NASDAQ 8-K 2024-04-18 DE 001-37695 20-8436652 7683 SE 27th Street Suite 481 Mercer Island WA 98040 (206) 378-0400 false false false false Common Stock, par value $0.001 per share KA false